Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragen

Beitragende

  • Mev Dominguez-Valentin - , Institute of Cancer Research (Autor:in)
  • Saskia Haupt - , Universitätsklinikum Heidelberg (Autor:in)
  • Toni T Seppälä - , Tampere University Hospital (Autor:in)
  • Julian R Sampson - , Cardiff University (Autor:in)
  • Lone Sunde - , Aalborg University (Autor:in)
  • Inge Bernstein - , Department of Molecular and Clinical Cancer Medicine and. (Autor:in)
  • Mark A Jenkins - , University of Melbourne (Autor:in)
  • Christoph Engel - , Universitätsklinikum Leipzig (Autor:in)
  • Stefan Aretz - , Universitätsklinikum Bonn (Autor:in)
  • Maartje Nielsen - , Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Gabriel Capella - , Hospitalet de Llobregat (Autor:in)
  • Francesc Balaguer - , Instituto de Salud Global de Barcelona (Autor:in)
  • Dafydd Gareth Evans - , Manchester University NHS Foundation Trust (Autor:in)
  • John Burn - , Newcastle University (Autor:in)
  • Elke Holinski-Feder - , Campus Innenstadt (Autor:in)
  • Lucio Bertario - , IRCCS Istituto Europeo di Oncologia - Milano (Autor:in)
  • Bernardo Bonanni - , IRCCS Istituto Europeo di Oncologia - Milano (Autor:in)
  • Annika Lindblom - , Karolinska Institutet (Autor:in)
  • Zohar Levi - , Rabin Medical Center Israel (Autor:in)
  • Finlay Macrae - , Royal Melbourne Hospital (Autor:in)
  • Ingrid Winship - , Royal Melbourne Hospital (Autor:in)
  • John-Paul Plazzer - , Royal Melbourne Hospital (Autor:in)
  • Rolf Sijmons - , University of Groningen (Autor:in)
  • Luigi Laghi - , University of Parma (Autor:in)
  • Adriana Della Valle - , Hospital Fuerzas Armadas (Autor:in)
  • Karl Heinimann - , Universitätsspital Basel (Autor:in)
  • Tadeusz Dębniak - , International Hereditary Cancer Center (Autor:in)
  • Robert Fruscio - , Università degli Studi di Milano Bicocca (Autor:in)
  • Francisco Lopez-Koestner - , Clínica Universidad de los Andes (Autor:in)
  • Karin Alvarez-Valenzuela - , Clínica Universidad de los Andes (Autor:in)
  • Lior H Katz - , Hebrew University of Jerusalem (Autor:in)
  • Ido Laish - , Hebrew University of Jerusalem (Autor:in)
  • Elez Vainer - , Hadassah Medical Center (Autor:in)
  • Carlos Vaccaro - , Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires (Autor:in)
  • Dirce Maria Carraro - , A.C.Camargo Cancer Center (Autor:in)
  • Kevin Monahan - , St. Mark's Hospital and Academic Institute (Autor:in)
  • Elizabeth Half - , Gastrointestinal Cancer Prevention Unit (Autor:in)
  • Aine Stakelum - , St Vincent's University Hospital (Autor:in)
  • Des Winter - , St Vincent's University Hospital (Autor:in)
  • Rory Kennelly - , St Vincent's University Hospital (Autor:in)
  • Nathan Gluck - , Tel Aviv University (Autor:in)
  • Harsh Sheth - , Institute of Medical and Human Genetics (Autor:in)
  • Naim Abu-Freha - , Soroka Medical Center (Autor:in)
  • Marc Greenblatt - , University of Vermont (Autor:in)
  • Benedito Mauro Rossi - , Hospital Sirio-Libanes (Autor:in)
  • Mabel Bohorquez - , University of Tolima (Autor:in)
  • Giulia Martina Cavestro - , Vita-Salute San Raffaele University (Autor:in)
  • Leonardo S Lino-Silva - , Surgical Pathology (Autor:in)
  • Karoline Horisberger - , Universitätsspital Zürich (Autor:in)
  • Maria Grazia Tibiletti - , Ospedale di Circolo ASST Settelaghi (Autor:in)
  • Ivana do Nascimento - , Universidade Federal do Recôncavo da Bahia (Autor:in)
  • Huw Thomas - , Imperial College London (Autor:in)
  • Norma Teresa Rossi - , Fundación para el Progreso de la Medicina" y "Sanatorio Allende" (Autor:in)
  • Leandro Apolinário da Silva - , Hospital Universitário Oswaldo Cruz (Autor:in)
  • Attila Zaránd - , Semmelweis University (Autor:in)
  • Juan Ruiz-Bañobre - , University of Santiago de Compostela (Autor:in)
  • Vincent Heuveline - , Universitätsklinikum Heidelberg (Autor:in)
  • Jukka-Pekka Mecklin - , University of Jyväskylä (Autor:in)
  • Kirsi Pylvänäinen - , Technische Universität Dresden (Autor:in)
  • Laura Renkonen-Sinisalo - , University of Helsinki (Autor:in)
  • Anna Lepistö - , University of Helsinki (Autor:in)
  • Päivi Peltomäki - , University of Helsinki (Autor:in)
  • Christina Therkildsen - , Copenhagen University Hospitals (Autor:in)
  • Mia Gebauer Madsen - , Aarhus University Hospital (AUH) (Autor:in)
  • Stefan Kobbelgaard Burgdorf - , Copenhagen University Hospitals (Autor:in)
  • John L Hopper - , University of Melbourne (Autor:in)
  • Aung Ko Win - , University of Melbourne (Autor:in)
  • Robert W Haile - , Stanford University (Autor:in)
  • Noralane Lindor - , Department of Health Science Research (Autor:in)
  • Steven Gallinger - , University of Toronto (Autor:in)
  • Loïc Le Marchand - , University of Hawai'i at Mānoa (Autor:in)
  • Polly A Newcomb - , Fred Hutchinson Cancer Research Center (Autor:in)
  • Jane Figueiredo - , Fred Hutchinson Cancer Research Center (Autor:in)
  • Daniel D Buchanan - , University of Melbourne (Autor:in)
  • Stephen N Thibodeau - , Department of Laboratory Medicine and Pathology (Autor:in)
  • Magnus von Knebel Doeberitz - , Universitätsklinikum Heidelberg (Autor:in)
  • Markus Loeffler - , Universitätsklinikum Leipzig (Autor:in)
  • Nils Rahner - , Universitätsklinikum Düsseldorf (Autor:in)
  • Evelin Schröck - , Institut für Klinische Genetik, Nationales Zentrum für Tumorerkrankungen (NCT) Heidelberg, Deutsches Krebsforschungszentrum (DKFZ), Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Verena Steinke-Lange - , Medizinische Klinik und Poliklinik I (Autor:in)
  • Wolff Schmiegel - , Ruhr-Universität Bochum (Autor:in)
  • Deepak Vangala - , Ruhr-Universität Bochum (Autor:in)
  • Claudia Perne - , Universitätsklinikum Bonn (Autor:in)
  • Robert Hüneburg - , Universitätsklinikum Bonn (Autor:in)
  • Silke Redler - , Universitätsklinikum Düsseldorf (Autor:in)
  • Reinhard Büttner - , Universitätsklinikum Köln (Autor:in)
  • Jürgen Weitz - , Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie (Autor:in)
  • Marta Pineda - , Hospitalet de Llobregat (Autor:in)
  • Nuria Duenas - , Hospitalet de Llobregat (Autor:in)
  • Joan Brunet Vidal - , Hospitalet de Llobregat (Autor:in)
  • Leticia Moreira - , Instituto de Salud Global de Barcelona (Autor:in)
  • Ariadna Sánchez - , Instituto de Salud Global de Barcelona (Autor:in)
  • Eivind Hovig - , Institute of Cancer Research (Autor:in)
  • Sigve Nakken - , Institute of Cancer Research (Autor:in)
  • Kate Green - , Manchester University NHS Foundation Trust (Autor:in)
  • Fiona Lalloo - , Manchester University NHS Foundation Trust (Autor:in)
  • James Hill - , Central Manchester and Manchester Children's University Hospitals NHS Trust, University of Manchester (Autor:in)
  • Emma Crosbie - , Manchester University NHS Foundation Trust (Autor:in)
  • Miriam Mints - , Karolinska-Universitätskrankenhaus (Autor:in)
  • Yael Goldberg - , Raphael Recanati Genetic Institute (Autor:in)
  • Douglas Tjandra - , Royal Melbourne Hospital (Autor:in)
  • Sanne W Ten Broeke - , University of Groningen (Autor:in)
  • Revital Kariv - , St Vincent's University Hospital (Autor:in)
  • Guy Rosner - , St Vincent's University Hospital (Autor:in)
  • Suresh H Advani - , Sushrut Hospital and Research Centre (Autor:in)
  • Lidiya Thomas - , Sushrut Hospital and Research Centre (Autor:in)
  • Pankaj Shah - , Zydus Cancer Centre (Autor:in)
  • Mithun Shah - , Zydus Cancer Centre (Autor:in)
  • Florencia Neffa - , University of Parma (Autor:in)
  • Patricia Esperon - , University of Parma (Autor:in)
  • Walter Pavicic - , Hospital Italiano de Buenos Aires (Autor:in)
  • Giovana Tardin Torrezan - , Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires (Autor:in)
  • Thiago Bassaneze - , University of Vermont (Autor:in)
  • Claudia Alejandra Martin - , Hospital Privado Universitario de Córdoba (Autor:in)
  • Gabriela Moslein - , Witten/Herdecke University (Autor:in)
  • Pål Moller - , Institute of Cancer Research (Autor:in)

Abstract

BACKGROUND: The Prospective Lynch Syndrome Database (PLSD) collates information on carriers of pathogenic or likely pathogenic MMR variants (path_MMR) who are receiving medical follow-up, including colonoscopy surveillance, which aims to the achieve early diagnosis and treatment of cancers. Here we use the most recent PLSD cohort that is larger and has wider geographical representation than previous versions, allowing us to present mortality as an outcome, and median ages at cancer diagnoses for the first time.

METHODS: The PLSD is a prospective observational study without a control group that was designed in 2012 and updated up to October 2022. Data for 8500 carriers of path_MMR variants from 25 countries were included, providing 71,713 years of follow up. Cumulative cancer incidences at 65 years of age were combined with 10-year crude survival following cancer, to derive estimates of mortality up to 75 years of age by organ, gene, and gender.

FINDINGS: Gynaecological cancers were more frequent than colorectal cancers in path_MSH2, path_MSH6 and path_PMS2 carriers [cumulative incidence: 53.3%, 49.6% and 23.3% at 75 years, respectively]. Endometrial, colon and ovarian cancer had low mortality [8%, 13% and 15%, respectively] and prostate cancers were frequent in male path_MSH2 carriers [cumulative incidence: 39.7% at 75 years]. Pancreatic, brain, biliary tract and ureter and kidney and urinary bladder cancers were associated with high mortality [83%, 66%, 58%, 27%, and 29%, respectively]. Among path_MMR carriers undergoing colonoscopy surveillance, particularly path_MSH2 carriers, more deaths followed non-colorectal Lynch syndrome cancers than colorectal cancers.

INTERPRETATION: In path_MMR carriers undergoing colonoscopy surveillance, non-colorectal Lynch syndrome cancers were associated with more deaths than were colorectal cancers. Reducing deaths from non-colorectal cancers presents a key challenge in contemporary medical care in Lynch syndrome.

FUNDING: We acknowledge funding from the Norwegian Cancer Society, contract 194751-2017.

Details

OriginalspracheEnglisch
Aufsatznummer101909
Seiten (von - bis)101909
FachzeitschriftEClinicalMedicine
Jahrgang58
PublikationsstatusVeröffentlicht - Apr. 2023
Peer-Review-StatusNein

Externe IDs

PubMedCentral PMC10166779
Scopus 85153285119

Schlagworte

Ziele für nachhaltige Entwicklung

ASJC Scopus Sachgebiete

Schlagwörter

  • Cancer risk, Lynch syndrome, MLH1, Mortality, MSH2, MSH6, PMS2, Prospective study, Survival

Bibliotheksschlagworte